CAITLYN CHAPLAIN: Open Payments
NPI 1407495864 · METAIRIE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$836 in 16 payments from 9 companies in 2025. Trend: 2023 $85 · 2024 $501 · 2025 $836
Food & beverage: $800Education: $36
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 6 | $389 |
| GlaxoSmithKline, LLC. | 1 | $125 |
| AstraZeneca Pharmaceuticals LP | 1 | $118 |
| UROGEN PHARMA, INC. | 2 | $74 |
| Sumitomo Pharma America, Inc. | 2 | $54 |
| Janssen Biotech, Inc. | 1 | $23 |
| Endo USA, Inc. | 1 | $22 |
| ABBVIE INC. | 1 | $18 |
| Lundbeck LLC | 1 | $15 |
Products named: INTERSTIM, NUCALA, TEZSPIRE, GEMTESA, ZUSDURI, AVEED, AVYCAZ, VYEPTI.
Industry payments across LA — which companies pay providers there.
